Clinical Trial

Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial

Not Yet Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated December 3, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
We are looking to see if patients using both topical testosterone and estrogen will have a greater improvement in pain with vaginal penetration compared to those using topical estrogen alone.
Trial Details
NCT Number NCT07260825
Lead Sponsor TriHealth Inc.
Conditions Vulvodynia, Dyspareunia, Lichen Sclerosus of Vulva
Enrollment 44 participants
Start Date 2025-12
Primary Completion 2026-07 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-12-03